Patents by Inventor James Rusche

James Rusche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Affinity chromatography media and chromatography devices
    Patent number: 11229896
    Abstract: Chromatography media and devices containing chromatography media are disclosed. Methods of making chromatography devices and methods of using chromatography devices containing the chromatography media are also disclosed.
    Type: Grant
    Filed: January 15, 2015
    Date of Patent: January 25, 2022
    Assignees: W.R. Grace & Co.—CONN., Repligen Corporation
    Inventors: Feng Gu, Surya Kiran Chodavarapu, James Bogdanor, Dennis McCreary, James Neil Pryor, James Rusche, James Peyser, Thomas Pauly
  • Affinity Chromatography Media and Chromatography Devices
    Publication number: 20160332142
    Abstract: Chromatography media and devices containing chromatography media are disclosed. Methods of making chromatography devices and methods of using chromatography devices containing the chromatography media are also disclosed.
    Type: Application
    Filed: January 15, 2015
    Publication date: November 17, 2016
    Applicants: W. R. GRACE & CO. CONN., REPLIGEN CORPORATION
    Inventors: Feng Gu, Surya Kiran Chodavarapu, James Bogdanor, Dennis McCreay, James Neil Pryor, James Rusche, James Peyser, Thomas Pauly
  • Use of secretin and secretin analogs to treat affective disorders
    Publication number: 20050002922
    Abstract: The invention is based, in part, on the discovery that secretin and secretin analogs can be used to treat affective disorders that include symptoms of anxiety. Secretin and secretin analogs can be administered to patients to treat affective disorders, such as mood, psychotic, mental, substance-abuse withdrawal, eating, and sexual disorders, as well as other disorders with attendant sensory processing dysfunction, including symptoms of anxiety and/or fear. In addition, secretin and secretin analogs can be administered to improve cognition, including learning and memory, as well as to lessen the effects of conditioned startle. Secretin has the added benefit of causing no negative side effects upon administration and being easy to administer.
    Type: Application
    Filed: March 12, 2004
    Publication date: January 6, 2005
    Inventors: Richard Boismenu, James Rusche, Martin Goulet
  • Cloning and expression of ligninases
    Patent number: 5616473
    Abstract: The gene encoding the ligninase rLDM.TM. 6 has been cloned and expressed. The ligninases produced via the processes disclosed herein are useful to degrade or modify lignin in pulp operations.
    Type: Grant
    Filed: August 8, 1994
    Date of Patent: April 1, 1997
    Assignee: Clariant Finance (BVI) Limited
    Inventors: Roberta L. Farrell, Paul Gelep, Algis Anilionis, Kashayar Javaherian, Theodore E. Maione, James Rusche, Bruce A. Sadownick, Jennifer A. Jackson